chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Reports that joint pain and periodontal disease flared up; slight arm pain, on-going emotional distress and stress eating. Believes that his pre-existing conditions were worsened, including loosened teeth due to COVID-19 Moderna  first vaccine  (left arm) on 2-19-2021 at 9 a.m. Second vaccine on 3-26-2021.
When leaving post vaccine, numbness and tingling of right foot, over the next 7 days spread numbness to both lower extremity extending into calf?s.  Burning nerve sensation started at day 7  increased up legs into hips.  Numbness and burning sensation bilateral from feet to hip
This spontaneous report as received from an office manager refers to a 57 year old patient of unknown gender. No pertinent medical history, concurrent conditions, drug reactions allergies or concomitant therapies were provided. On 30-JUN-2017, the patient was vaccinated with pediatric RECOMBIVAX HB 5/0.5 mcg/ml for prophylaxis (dose, route, indication, lot number and expiration date were not reported) due to a human error. No adverse effects were reported. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1707USA005560.
Information was received from a nurse practitioner regarding a 15 year old female, no known allergies, who was vaccinated with a first dose of  GARDASIL on 22-JUL-2011. The patient received a second dose of GARDASIL (Lot #672547/1745AA) (Expiration: 13-SEP-2014) on 17-JUL-2012. After receiving the vaccination, on 17-JUL-2012, a urine pregnancy test was positive. The patient has non relevant medical history or concomitant medications. On 17-JUL-2012, a blood test to confirm pregnancy was sent out and the results are pending. As of 17-JUL-2012, the patient planned to finish the series and the outcome of the exposure in utero is unknown. It was noted the patient was vaccinated with Tdap (manufacturer not specified) on an unknown date, but is not current on any other vaccinations. Follow-up information was received as due date was approximately April 2013. Additional information is not expected.
I noticed a few hives on his lower leg (both right and left).  At first there were just 6, and they were flat and red.  My husband and I both studied them, and they were completely smooth, within the next 3 hours he developed a total of 11 hives, and they turned into raised angry looking welts.  I called the doctor and was instructed to put hydrocortisone cream on hives and administer Benadryl. It took 3 days for the hives to go away with this course of action.  I even called the doctor back again because it was taking so long, but was advised to continue as told.
Approximately 5 minutes after receiving vaccine, patient experienced itching on upper lip and itching on left upper arm.  Appears to have a petechial rash with redness on left upper arm.  Itching is stable and not getting worse.  Left arm feels a little heavy with some unusual sensation.  Initial BP 155/91 HR=80.  O2=98%.  Repeat BP 137/90 HR=77  O2=97%.  Patient declined Benadryl because the symptoms are stable and patient did not want to get sleepy from the Benadryl and patient wanted to return to work.  Patient clinically stable.  Patient released at 10:15am.
Lots of pain in my shoulder for three months; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Lots of pain in my shoulder for three months) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Lots of pain in my shoulder for three months). At the time of the report, ARTHRALGIA (Lots of pain in my shoulder for three months) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Dry cough; Night sweats; soreness at the injection site; Fatigue; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Dry cough), NIGHT SWEATS (Night sweats), VACCINATION SITE PAIN (soreness at the injection site), FATIGUE (Fatigue) and NAUSEA (Nausea) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058E21A., 018B21A and 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Seizure and Cholesterol. Concomitant products included ROSUVASTATIN for Cholesterol, LEVETIRACETAM (KEPRA) and LAMOTRIGINE (LAMICTAL) for Seizure.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Sep-2021, the patient experienced COUGH (Dry cough), NIGHT SWEATS (Night sweats), VACCINATION SITE PAIN (soreness at the injection site), FATIGUE (Fatigue) and NAUSEA (Nausea). On 22-Sep-2021, NIGHT SWEATS (Night sweats) had resolved. On 23-Sep-2021, NAUSEA (Nausea) had resolved. At the time of the report, COUGH (Dry cough), VACCINATION SITE PAIN (soreness at the injection site) and FATIGUE (Fatigue) had not resolved.            Treatment drug was not reported.
Patient was vaccinated on 17 October 2021 with Pfizer/BioNTech, as ordered. Patient reports that he had a few episodes of chest pain prior to presenting to the ER on 28 Sep 2021, but ignored them because he is young, and he did not know the vaccine could case heart problems and his symptoms were not initially severe.  On 28 Sep 2021, Patient had mowed his lawn at 1230 and then went to class, where he was sitting in a chair and when he leaned forward his chest got tight with shortness of breath, that resolved when he leaned back but returned when he leaned forward again. Patient called Health Clinic for advice or to get an appointment and was advised to go to local ER.  Patient took the vaccine because he was told that he would not be required to get the vaccine unless it was FDA approved. Patient reports that Pfizer BioNtech and Pfizer Comminarty were the same. Patient reports that he absolutely would NOT have taken the vaccine if he knew it was not the FDA approved Pfizer vaccine.
screaming x 8-9 hrs on 27AUG93 beginning w/in 30 mins of vax;
Enlarged lymph node under arm of injection site (left/approximately 10cm), painful, slight warmth to touch. No redness noted. On 6/5/00, lump is decreased in size with less pain.
On 11/08/2022 I received my Covid-19 vaccine. On 01/16/2023 I started feeling very tired. I did a home test for Covid-19 and was tested positive. After reaching out to my doctor I was prescribed Paxlovid for 5 days.
A non-serious spontaneous report of inadvertently give half dose of H1N1 was received from a nurse/health professional concerning a 45-year-old female. The patient's medical history and concomitant medications was not reported. On 27-Oct-2009, the patient was inadvertently given half dose of H1N1, Intranasal. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
Narrative:  Patient received two doses of Pfizer COVID 19 vaccine in Jan/Mar 2021. The patient tested positive for COVID 19 on 20 August 21 and was hospitalized for minor Covid symptoms. Over the next several weeks, the patient experienced significant worsening in COVID pneumonia symptoms and was treated. He was discharged and re-admitted on two occasions. The patient was then discharged to an LTAC and then the patient's condition worsened and the patient died on 22 September 2021.
I had Covid in June - and felt the same - fever (not real high - 101), chills, nausea, no energy, headache - lasted from 7pm ish until sometime around 5am woke up sweating and only had slight headache that went away after some fluids - it was not fun at all, but didn't last too long - I didnt take any Advil until about 2 am, then could sleep. Stayed home Monday because I could, but by noon felt nearly 100%, by 6pm felt 100%.
I noticed the night of 1/21/2021 that my arm was itchy. Looking at it there was a red raised bump at the injection site that had not previously been there. Since having the vaccine the only other effect I had was arm soreness the day of and day after the shot.
weak; tired; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak) and FATIGUE (tired) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included INSULIN for an unknown indication.    On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-May-2021, the patient experienced ASTHENIA (weak) and FATIGUE (tired). At the time of the report, ASTHENIA (weak) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details were provided. concomitant medications included bipolarity Patient received first dose of Moderna Covid-19 vaccine on 21May2021. It was administered on the left nondominant arm. Patient has been feeling weak and tired since 22May2021. Symptoms have not improved. Patient did not take medication to treat symptoms.
pt recvd vax 30AUG93 1 wk later felt funny on 6SEP93; high fever 103.7 on 9SEP93; down to 99.0 w/APAP several days a/reporting; on & off nausea & vomiting; chest aches, rash beginning 12SEP93 over chest & face;
This spontaneous report as received from a nurse practitioner and refers to a patient of unknown age and gender. On 27-APR-2012, the patient was vaccinated with the first dose of improperly stored VARIVAX lot # 1273AA. On 29-MAY-2012, the patient was vaccinated with the second dose of improperly stored VARIVAX lot#: 671861/1907AA. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous case reported by a consumer, describes the occurrence of nasal congestion (stuffy nose), pyrexia (fever) and myalgia (arm hurts) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Apr 6, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On May 7, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On May 7, 2021, patient experienced nasal congestion (stuffy nose), pyrexia (fever) and myalgia (arm hurts). At the time of the report, nasal congestion (stuffy nose), pyrexia (fever) and myalgia (arm hurts) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): not applicable. Concomitant medications and treatment information not provided.
Shaking; Spastic shake; Thinking abnormal; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking), ATAXIA (Spastic shake) and THINKING ABNORMAL (Thinking abnormal) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported. Concomitant products included ALLOPURINOL, ATORVASTATIN, ENALAPRIL, GLIBENCLAMIDE, SITAGLIPTIN, LEVOTHYROXINE, FUROSEMIDE, METFORMIN, TAMSULOSIN, RIVAROXABAN, FINASTERIDE, DILTIAZEM and INSULIN GLARGINE for an unknown indication. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced TREMOR (Shaking), ATAXIA (Spastic shake) and THINKING ABNORMAL (Thinking abnormal). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form. On 03-Feb-2021, TREMOR (Shaking), ATAXIA (Spastic shake) and THINKING ABNORMAL (Thinking abnormal) had resolved. Not Provided. This case was linked to MOD-2021-016347 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 01-Apr-2021: Follow up received on 01-Apr-2021 contains non significant information.; Reporter's Comments: This case concerns a 68-year-old male who experienced nonserious unexpected events of tremor, ataxia, and feeling abnormal. The events occurred 2 days after the second of mRNA-1273. Treatment included acetaminophen. Event outcome resolved. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
First dose > 35 days ago; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose > 35 days ago) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose > 35 days ago). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose > 35 days ago) had resolved.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
4/24/2022-Presented to ED, unwitnessed fall states hit head large hematoma on L eye, admitted to drinking alcohol daily. Confused. CT Had, R parafalcine subdural and L frontal/parietal subdural hygroma. CT-sacral fracture and L subtrochanteric femur fx. Covid -test.  Baseline 02 use 2L NC. Increased to 3L intermittently desat to mid 80's.Admit intraparenchymal hemorrhage with subdural hematoma s/t to fall.  4/25/2022-Left subtrochanteric hip fracture repair. R occiptal intraparenchymal hemorrhage inceased to 1.5cm L anterior frontal intraparenchymal hemorrhage increased to 5mm. No surgical intervention. BP controlled less then 140/80  currently 104/62, o2 sat 90's on 3L NC.  Keppra 750mg BID. ST eval clear liquids, swallowing difficulties. 4/26/2022- R occipital intraparenchymal hemorrhage  stable on f/u CT.  4/27/2022-On NRB, sat in mid 70's, o2 changed to 5L sata now 88-92%.  4/28/2022-AM-Mentation decline, desat 70-80 becoming more altered, fine wheezes bilateral and creptation on R side. Placed on NRB 15L. CXR-mod airpace disease/infiltrates  LAsix IV and levaquin , CT no evidence of PE. IVC filter placed to prevent PEd/t recent surgery and immobility.  PM-Sats in high 90's with NRB, but patient would not keep on, desatting to 70's. 5L NC was placed so suctioning could occur, sats would not maintain over 70%, thick yellow sputum obtained by suction. Became tachy and transfered to ICU and intubated.  Acute on chronic hypoxemic resp failure s/t to ARDS d/t pneumonia vs pulm edema in setting of HFrEF and AMS. Current bilevel  setting FiO2 60%.  4/29/2022-Bilevel 16 25/10 35%. WBC and h&h stable. On Vanco cefepime and flagyl.  4/30/2022- recent echo showed severe L ventricular dilatation with moderate miral regurg EF 20%. Continue entresto hold toresemide 5/2/2022- Exubated on 2L NC. Continue cefepime and flagyl. 5/3/2022- WBC 15.4 from 13.3  ABG 7.453/31.9/66/22.3/90 cxr-pulmonary vascular congestion and cardiomegaly. Cont digoxin and metoprolol 5/5/2022- Transfered to ICU. Wears bipap at HS. o2 sat on 2L stable.  5/13/2022- Rapid response called  Acute RF, hypoxic 80's on sat , tachypneic using resp muscles. BP 154/104  RR 24  ABG 7.45/25/97/18/ on NRB  worsening CT chest -pulmonary infiltrates and b/l pleural effusion.  Bipap with PEEP 8.   Continued  distress, intubated and transfered to ICU. Chest Ct consisten with b/l diffuse groundglass opacities/  Covid + test.  Ferritin 535.0. Started on steroids, barcitinib, remdesivir, vitamins and heparin.  Cefepime and Vanco. 5/15/2022- Vent 12 22/6 60% 5/17/2022-Palliative orders placed d/t severe HF and mitral valve issues, fluid is in lungs and she is at high risk for reintubation if extubation is attempted. Terminally exubated. Morphine increased.  WBC 15.5  5/19/2022- Time of death  1003.
This injection caused frozen shoulder. The pain started the same day and I assumed it was normal to have pain at the injection site. The pain got worse and worse and never resolved.  I thought about having the second shot done on the right shoulder since the left side soreness never went away. But I had in on the left side and although it got sore, that soreness from the second shot dissipated in two days. The soreness from the first shot still hadn't resolved and the shoulder had started losing ROM after the first injection but I didn't really notice until it became "frozen" and very painful in March.  I have been seeing a chiropractor, acupuncturist and saw an orthopedic doctor. I am scheduled to start PT in 2 weeks. It is still very painful and very limited ROM.  I am hoping this isn't a permanent disability because this started right after the injection in January and here we are in May!
COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment.    Concurrent medical conditions included Drug allergy. Concomitant products included AMITRIPTYLINE, FINASTERIDE and TAMSULOSIN for an unknown indication.   On 04-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 27-May-2022, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-May-2022, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It had been reported that the patient taken other medications/products within 2 weeks of starting COVID-19 treatment. Company comment: This spontaneous case concerns a 66-year-old, male patient with no relevant medical history, who experienced the unexpected, non-serious AESI of COVID-19. The event occurred 43 days after administration of fourth dose of mRNA-1273, there was no information provided regarding the initial three doses. Patient underwent treatment regimen of Paxlovid on May 17, 2022, 3 days after completion of the regimen, patient experienced rebound symptoms and a positive result on the antigen test. On May 27, 2022, patient underwent SARS-CoV-2 test which revealed a positive result. Details of concomitant medications and clinical course were not provided. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a 66-year-old, male patient with no relevant medical history, who experienced the unexpected, non-serious AESI of COVID-19. The event occurred 43 days after administration of fourth dose of mRNA-1273, there was no information provided regarding the initial three doses. Patient underwent treatment regimen of Paxlovid on May 17, 2022, 3 days after completion of the regimen, patient experienced rebound symptoms and a positive result on the antigen test. On May 27, 2022, patient underwent SARS-CoV-2 test which revealed a positive result. Details of concomitant medications and clinical course were not provided. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Fever, chills, posterior neck soreness, arm soreness (at injection site), vomiting, sore throat, joint pains, dizziness, possible mild confusion.
dizziness, faint, low blood pressure, sweating.   patient laid down and put legs up on a chair, blood pressure returned to normal and patient felt better
Call regarding swelling post vaccination. Patient is known to me and sent a text on 3/3/19 stating the following: "So this huge cyst popped up yesterday right at the injection point of my shot (received MMR vaccine 1/30/19). It hurts really bad today. Like anytime it gets bumped or rubbed I feel like crying. Is this usual? Any advice?" I texted back: "A harder bump isn't uncommon a week or two later. But I've never heard of symptoms that late. 5% of people can get a rash a week or two after but it's not painful. Can u send a picture of the whole back of your arm?" First photos she texted were not clear and I responded: "I can't see a cyst in any of the pictures. Is it just red? Is it raised at all? I'll ask about it when I see the doctor next. Any fever?" She sent a better photo the next day (3/4/19) and she replied, "It is hard and hot now. The hard part is about 1 x 2 inches and then swollen and red around it." I forwarded the photo of her arm to my supervisor to view and review with a doctor at the health department. I then left her a phone msg and also texted her back to go to urgent care (is currently traveling) to r/o cellulitis and see if she needed an ABO.  Will also initiate VAERS report and YCCHS incident report. RN
A couple days after I begin experiencing general body aches, headache and nausea which lasted about 10 days after.  I got a COVID swab which was negative.
Given COVID19 vaccine out of age range; patient is 17, and vaccine approved for 18 and above.
Rash on stomach, back and neck, gradually got worse for 2 more days. Gave Benadryl but didn't go away. Had a low grade fever of 100.5 to 101.5 for 2 days prior with no symptoms until the rash.
The affected individual called clinic two days after immunization to report concerns. Immunization was on 2-11-20, and she spoke with this nurse on 2-13-20. She reported to this RN on 2-13-20 that within a few hours of receiving the vaccine, she became severely dizzy, broke out in hives, had nausea and vomiting. Hives worsened over the next day to the point she reports she was covered in hives from head to toe. Localized swelling and redness at injection site.  She reports the area was red, not just pink. Nausea/vomiting continued for the next two days. RN directed her to go to ED. ED evaluation:
Received 2nd dose less than 24 days from 1st dose (23 days).
Swelling, redness, soreness, hot to touch. By Friday it was worse went to doctor - not sure if from shot or what, allergic reaction, infection or heading into staph infection - given antibiotics, claritin and Ibuprofen - Got better but didn't go away. Noticed on July 22nd it was red again, hot to touch, bumpy and blistering - Went to doctor for the third time and diagnosed as a type of contact infection - given steroid shot and a cortisone-steroid creme to apply to it twice a day. It is now Monday July 16th and it is disappearing, hopefully this time it won't come back.
This spontaneous report as received from a licensed practical nurse refers to a 61 year old female patient with allergic rhinitis. Information regarding relevant medical history and concomitant medications were not reported. On 04-OCT-2012, the patient was vaccinated with PNEUMOVAX 23 (dose, route and lot # not reported). After receiving the vaccine, on an unknown date, the patient's arm swelled and there was redness. The patient also had a welt the size of a goose egg. The outcome of the events was unknown. Additional information has been requested.